Frequently Asked Questions
In 2022, the global Genu Recurvatum Market is expected to be worth USD 6748.5 million.
The Genu Recurvatum Market is estimated to increase at a CAGR of 5.90% between 2023 and 2030, reaching USD 10675.1 Million in 2030.
In 2022, The Hypertension with Weight-Bearing category is, undoubtedly, the market leader in Genu Recurvatum
Orthopedic Clinics is the fastest expanding segment of the Genu Recurvatum market.
The Surgical Treatment category has the greatest CAGR (Compound Annual Growth Rate).
North America dominates the market for genu recurvatum. It controls nearly 40% of the market, giving it the highest percentage share and the highest market value.
The top players include DePuy Synthes Companies, Globus Medical, Inc., Medtronic Plc, NuVasive, Inc., Smith & Nephew Plc, Zimmer Inc., Stryker Corporation.
The primary market drivers are the aging population, changes in lifestyle, and genetic predisposition.
Obstacles in the market include a scarcity of qualified professionals, restricted access and quality of treatment, and a lack of awareness and education.
Opportunities in the market include advancements in research and treatment choices, improved access to healthcare services, and technological improvements in surgical procedures and medical devices.